Inocta Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-06-2024
- Paid Up Capital ₹ 0.10 M
as on 19-06-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Inocta Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Kumar, Vikash Choubey, and Azad Deepak serve as directors at the Company.
- CIN/LLPIN
U51909BR2020PTC046596
- Company No.
046596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Inocta Pharmaceuticals Private Limited offer?
Inocta Pharmaceuticals Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Plasticizers.
Who are the key members and board of directors at Inocta Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Kumar  | Director | 17-Jun-2021 | Current |
| Vikash Choubey | Director | 02-Jul-2020 | Current |
| Azad Deepak | Director | 02-Jul-2020 | Current |
Financial Performance of Inocta Pharmaceuticals.
Enhance accessibility to Inocta Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Inocta Pharmaceuticals?
Unlock access to Inocta Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aztech Technology And Engineers Private LimitedActive 13 years 2 monthsAzad Deepak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inocta Pharmaceuticals?
Inocta Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inocta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inocta Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
